Misplaced Pages

The following pages link to Denosumab

• (link count
• transclusion count
• sorted list) · See help page for transcluding these entries

Showing 50 items.

• Strontium ranelate (links | edit)
• Lymphotoxin beta receptor (links | edit)
• Tiludronic acid (links | edit)
• Clodronic acid (links | edit)
• Gantenerumab (links | edit)
• Etaracizumab (links | edit)
• Biosimilar (links | edit)
• List of largest selling pharmaceutical products (links | edit)
• Ipriflavone (links | edit)
• Tumor necrosis factor receptor 1 (links | edit)
• Lymphotoxin alpha (links | edit)
• Lymphotoxin beta (links | edit)
• Tumor necrosis factor receptor 2 (links | edit)
• Functional hypothalamic amenorrhea (links | edit)
• Odanacatib (links | edit)
• Olpadronic acid (links | edit)
• Neridronic acid (links | edit)
• Incadronic acid (links | edit)
• Medication-related osteonecrosis of the jaw (links | edit)
• Ramucirumab (links | edit)
• Alacizumab pegol (links | edit)
• Tanezumab (links | edit)
• Solanezumab (links | edit)
• Bone metastasis (links | edit)
• Management of prostate cancer (links | edit)
• FREEDOM trial (links | edit)
• Indium (111In) biciromab (links | edit)
• Socket preservation (links | edit)
• Prolia (redirect page) (links | edit)
  • Amgen (links | edit)
  • User:The Anome/Moby nouns/P (links | edit)
  • User:Gjanko/sandbox (links | edit)
  • User:Suejanko/sandbox (links | edit)
  • User:Wissenswart/corpus analysis (links | edit)
  • User:LinguisticMystic/drug (links | edit)
• Anti-RANKL antibody (redirect page) (links | edit)
• Anti-RANK antibody (redirect page) (links | edit)
• ATC code M05BX04 (redirect page) (links | edit)
• ATCvet code QM05BX04 (redirect page) (links | edit)
• Xgeva (redirect page) (links | edit)
  • Amgen (links | edit)
  • List of drugs: X (links | edit)
  • User:Gjanko/sandbox (links | edit)
  • User:Suejanko/sandbox (links | edit)
  • User:LinguisticMystic/drug (links | edit)
  • Misplaced Pages:WikiProject Pharmacology/Top 200 US Prescriptions 2011 (links | edit)
• Minodronic acid (links | edit)
• RANK-L antibody (redirect page) (links | edit)
• Anti-RANK-L antibody (redirect page) (links | edit)
• RANK-L inhibitor (redirect page) (links | edit)
• Crenezumab (links | edit)
• Fulranumab (links | edit)
• Icrucumab (links | edit)
• Ponezumab (links | edit)
• Romosozumab (links | edit)
• Blosozumab (links | edit)
• Alirocumab (links | edit)
• Demcizumab (links | edit)
• Fasinumab (links | edit)
• Caplacizumab (links | edit)
• Inclacumab (links | edit)
• Nesvacumab (links | edit)